Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company LAM Therapeutics
DescriptionInhaled mammalian target of rapamycin (mTOR; FRAP; RAFT1) kinase Inhibitor
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat lymphangioleiomyomatosis (LAM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today